Egg-Freezing? Put Flex Time, Daycare First
By Jacqueline Nelson,
The Globe and Mail
| 02. 08. 2015
Untitled Document
Somewhere between calls to “break the glass ceiling” and the war cry to “have it all,” working women found themselves also saddled with the expectation they be it all: the breadwinner, caregiver, fitness queen, thoughtful BFF, sex goddess … the list, it seems, is infinitely expanding. Women strive to fulfill these roles while remaining on the losing end of the wage gap and continuing the hardscrabble fight for representation in the executive ranks (even as they make up nearly half the labour force in Canada).
The pressure is immense.
In stepped a few corporate giants with a plan meant to help young (and youngish) women across North America build their careers, while relieving them of pesky biological-clock considerations: Apple, Facebook and others started subsidizing egg freezing. This, Apple said at the time, could empower women “to do the best work of their lives as they care for loved ones and raise their families.”
The move elicited cheers for being a step forward for women – a progressive investment in historically inhospitable industries, such as tech and banking. And...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...